These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1339040)

  • 1. Comparability of poliovirus neutralizing antibody tests.
    Wood DJ; Heath AB
    Biologicals; 1992 Dec; 20(4):293-300. PubMed ID: 1339040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of poliovirus neutralizing antibody tests.
    Albrecht P; van Steenis G; van Wezel AL; Salk J
    Rev Infect Dis; 1984; 6 Suppl 2():S540-4. PubMed ID: 6330853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Second International Standard for anti-poliovirus sera types 1, 2 and 3.
    Wood DJ; Heath AB
    Biologicals; 1992 Sep; 20(3):203-11. PubMed ID: 1333776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serosurvey for polio antibodies.
    Biberi-Moroeanu S; Munţiu A; Stoiculescu S
    Virologie; 1988; 39(4):241-5. PubMed ID: 2851206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus neutralizing antibody persistence after vaccination with the Sabin vaccine: a follow-up study.
    Farisano G; Trivello R; Moschen ME; Bonello C; Baldo V; Moretti G; Majori S; Marin F; Piron L; Renzulli G
    Ann Clin Lab Sci; 1995; 25(2):200-6. PubMed ID: 7785968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified radial-plaque-neutralization test for demonstration of enterovirus neutralizing antibodies.
    Nagy G; Takátsy S
    Arch Virol; 1980; 65(2):89-98. PubMed ID: 6252870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated microtransfer technique for the assay of poliovirus- and mumps virus-neutralizing antibodies.
    Mayner RE; McDorman DJ; Meyer BC; Parkman PD
    Appl Microbiol; 1974 Dec; 28(6):968-71. PubMed ID: 4375437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative seroepidemiologic study of the neutralizing antibody against the virulent standard strains and the Sabin vaccine strains of poliovirus among healthy Japanese.
    Miyamura K; Ogino T; Takeda N; Utagawa E; Ikeda Y; Tanimura M; Hara M; Yamazaki S
    Jpn J Med Sci Biol; 1990 Oct; 43(5):141-9. PubMed ID: 1965511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
    Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
    Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiometric cytolysis inhibition assay, a new rapid test for neutralizing antibodies to intact and trypsin-cleaved poliovirus.
    Hovi T; Roivainen M
    J Clin Microbiol; 1989 Apr; 27(4):709-15. PubMed ID: 2542364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey.
    Murph JR; Grose C; McAndrew P; Mickiewicz C; Mento S; Cano F; Radick L; Ritchey M; Stout MG
    Pediatr Infect Dis J; 1988 Nov; 7(11):760-5. PubMed ID: 2852791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
    Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid methods for identification of poliovirus isolates and determination of polio neutralizing antibody titers in human sera.
    Di Lonardo A; Buttinelli G; Amato C; Novello F; Ridolfi B; Fiore L
    J Virol Methods; 2002 Mar; 101(1-2):189-96. PubMed ID: 11849697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.